Company profile
UK company 03810162, incorporated on 15 July 1999.
Gentronix - Experts in Predictive Toxicology
Gentronix provides services to help expedite the discovery, early-stage development and safe manufacture of novel drugs.
Company number 03810162
Updated 07 Jul 2026 09:49
Financial period: 1 Sep 2023 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jul 2014 to 31 Jul 2014
Continued innovation by the diverse chemical sectors is expected to provide new, better, and more effective medicines, herbicides, pesticides and consumer products. The public expects these to be safe as well as effective. Cancer risk is perhaps the most concerning. The most potent carcinogens are mutagens: compounds that alter the DNA sequences in our ce...
1 Feb 2013 to 30 Apr 2014
The human genome is complex and well protected by an array of systems that sense damage, and initiate repair. When damage is overwhelming, cells are usually forced into suicide to minimise the generation of viable mutant cells that might develop into tumours. Direct DNA damage is not the only threat to the genome. Tissues such as liver, kidney, muscle etc...
